The LILRB2 gene helps certain immune cells read “slow down” signals, which keeps immune responses more balanced and helps protect your body’s own tissues. If this gene does not work as it should, immune activity may become less controlled and may play a role in inflammation or the immune system reacting in the wrong way. Researchers also study the LILRB2 gene in cancer because it can influence how strongly immune cells respond to tumors.
What is a gene?
Genes are sections of DNA that store instructions your cells use to make molecules or direct processes in the body. Some provide the code for proteins, the parts of cells that do the work. Others mostly help determine when certain processes happen, where they happen, and how strongly they operate. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
LILRB2Gene function
What if the gene works
The LILRB2 gene helps certain immune cells recognize signals from healthy tissues. Its protein acts like a brake, reducing immune activity and helping control inflammation.
Risk
What if the gene does not work
If the LILRB2 gene works less well, immune cells may receive weaker inhibitory signals and react in a less controlled way. Milder to more severe variants can reduce receptor activity by different amounts and change signaling between cells.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the LILRB2 gene, no gene-specific treatment or management approach is currently established in clinical guidelines. The LILRB2 gene is being studied as a drug target, mainly in cancer immunotherapy, where blocking its activity may help improve immune responses.
Gene function
What if the gene works
In daily immune activity, the LILRB2 gene helps certain white blood cells stay measured rather than overreacting. It supports how these cells read signals from nearby cells and decide when to hold back. This steadying role is central to what the LILRB2 gene does in the immune system.
The LILRB2 gene helps make a receptor on monocytes, macrophages, and dendritic cells that sends a slow down signal. This keeps everyday immune reactions more controlled and supports normal immune balance.
This receptor can bind HLA class I markers, which are normal identity tags on many body cells. Reading these tags helps immune cells recognize healthy tissue and respond with more restraint.
Through this calming pathway, immune cells adjust how strongly they release chemical messengers and how powerfully they activate nearby T cells. This helps keep normal immune communication measured.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LILRB2 gene can change the shape of its receptor protein or how much of it reaches the surface of immune cells. In plain terms, this is how LILRB2 gene variants affect protein function: some slightly weaken binding to partner molecules, while more disruptive variants can make the receptor unstable or reduce its built in brake signal inside the cell. This functional impact can range from mild to more marked, depending on the exact variant.
How variants are linked to conditions
At present, LILRB2 gene variants linked to conditions have not been confirmed as a broad, well-established cause of any specific health condition. As research develops, anyone with a reported change in the LILRB2 gene should rely on advice from their doctor or genetic counselor for interpretation.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LILRB2 gene. If testing finds a change in LILRB2, a doctor or genetic counselor can help explain what it may mean in the context of your personal and family history.
Inheritance of LILRB2 variants
There is not yet a broadly confirmed, disease-specific Mendelian pattern for how LILRB2 gene variants are inherited, and research is still clarifying whether any particular LILRB2-related condition follows a consistent family pattern. For people looking into LILRB2 gene inheritance, it helps to know that the LILRB2 gene is located on chromosome 19, which is an autosome. That means you inherit one copy from your mother and one copy from your father.
What does my LILRB2 result mean for my family?
There is not yet a broadly confirmed inherited pattern linking LILRB2 to a specific genetic condition in the way seen with some other genes. If you have a LILRB2 result and want to understand what it may mean for relatives, a doctor or genetic counselor can help explain it in the context of your family history and the exact result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for LILRB2 variants usually uses a blood or saliva sample. A lab reads the LILRB2 gene with sequencing, sometimes as part of a larger gene panel, and compares it with a reference DNA sequence. Results may show a benign variant, a variant of uncertain significance, or a variant associated with a health condition.
When should I consider getting a genetic test?
There is not yet a broadly established, LILRB2-specific reason for genetic testing in routine care. Testing decisions are usually based on your personal health and family history, ideally with guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies with the condition and the kind of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or reacts to it at its target. This helps explain why the same treatment may work well for one person, seem weaker in another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It looks for relationships between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. You can learn more about this topic in the LearnHub.
Drugs influenced by the LILRB2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. For any concerns about your health, treatments, or side effects, speak with your doctor or pharmacist.
History
LILRB2 entered the scientific literature in the late 1990s, during a period when researchers were sorting out a growing family of immune system genes on chromosome 19. It was first described under names such as ILT4 and LIR2 before the standard name, the LILRB2 gene, became widely used. Scientific classifications changed as researchers learned more about the gene. Early work focused on how it fit into a larger group of receptors that help immune cells respond in a measured way. Over time, studies connected the LILRB2 gene to broader questions in human immunology, including transplant biology, infection, and inflammation. Its history is mainly a story of careful lab research rather than public attention, with its role becoming clearer as immune genetics advanced.